FibroGen Amends Financing Agreement to Reduce Minimum Cash Balance Requirement FibroGen revises financing terms to lower minimum cash balance, enhancing liquidity flexibility. #FibroGen #FinancingUpdate
Perpetua Resources Completes Option Share Sale, Raising Total Proceeds to $474 Million Perpetua Resources successfully completes option share sale, boosting total proceeds to $474M to support growth and development projects. #PerpetuaResources #CapitalRaise
Zivo Bioscience Launches $2 Million Convertible Debt Offering with Warrants Zivo Bioscience initiates $2M convertible debt offering with warrants to support growth and R&D. #ZivoBioscience #ConvertibleDebt
Pulse Biosciences Appoints Steven T. Weber as Principal Accounting Officer Pulse Biosciences appoints Steven T. Weber as Principal Accounting Officer to strengthen financial leadership and reporting. #PulseBiosciences #FinancialLeadership
Black Hawk Acquisition Extends Business Combination Deadline After Shareholder Vote Black Hawk Acquisition extends its business combination deadline following shareholder approval, allowing more time to identify strategic merger targets. #BlackHawkAcquisition #SPAC
GCM Grosvenor Announces Planned Resignation of Sandra Buchanan Effective October GCM Grosvenor announces Sandra Buchanan's planned resignation as CFO effective October, marking a key leadership transition. #GCMGrosvenor #LeadershipChange
Tvardi Therapeutics Director Shaheen Wirk Resigns from Board Tvardi Therapeutics announces resignation of director Shaheen Wirk, signaling potential shifts in governance. #TvardiTherapeutics #BoardResignation
Bancorp Expands Partnership with Block to Provide Card Services for Cash App Bancorp strengthens collaboration with Block, enhancing card services for Cash App users, driving growth and innovation. #Bancorp #Block #CashApp
Silexion Therapeutics Shareholders Approve Board Elections, Reverse Split, and Equity Plan Changes Silexion Therapeutics shareholders approve key governance changes including board elections, reverse stock split, and equity plan updates. #SilexionTherapeutics #CorporateGovernance
BK Technologies Grants Long-Term Performance Stock Options to CEO and CFO BK Technologies awards long-term performance stock options to CEO and CFO, aligning leadership incentives with company growth. #BKTechnologies #ExecutiveCompensation